MedPath

Clinical Trial of bilateral bevacizumab administration in patient with retinopathy of prematurity

Phase 3
Recruiting
Conditions
retinopathy of prematurity
Registration Number
JPRN-jRCT1091220083
Lead Sponsor
obuhisa Naoi, MDDepartment of Ophthalmology, School of medicine University of Miyazaki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria

Patient with retinopathy of prematurity admitted in Miyazaki University Hospital

Exclusion Criteria

none

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
retinal status
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath